British American Tobacco does not own 100% of Organigram, but it is the company's single largest strategic owner and primary corporate partner. Through a multi-tranche strategic investment agreement, BAT holds a major stake of approximately 30% in Organigram, providing both vital financial capital and collaborative global insights to help accelerate product development and international growth.